Samsara BioCapital’s Science 37 Holdings, Inc. Common Stock SNCE Stock Holding History

Samsara BioCapital’s Portfolio SNCE Stock Details SNCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-45,000	Closed	-$240K	–	41
2023 Q4	$240K	Hold	45,000	–	–	0.04%	37
2023 Q3	$360K	Hold	45,000	–	–	0.11%	37
2023 Q2	$191K	Hold	45,000	–	–	0.03%	43
2023 Q1	$253K	Hold	45,000	–	–	0.05%	49
2022 Q4	$374K	Hold	45,000	–	–	0.08%	46
2022 Q3	$1.45M	Hold	45,000	–	–	0.34%	40
2022 Q2	$1.81M	Hold	45,000	–	–	0.48%	37
2022 Q1	$4.82M	Hold	45,000	–	–	1.21%	19
2021 Q4	$11.2M	Buy	+45,000	New	+$9.99M	2.18%	12
2021 Q3	–	Sell	-10,000	Closed	-$2M	–	50
2021 Q2	$2M	Hold	10,000	–	–	0.25%	43
2021 Q1	$2.03M	Hold	10,000	–	–	0.37%	39
2020 Q4	$2.13K	Buy	+10,000	New	+$2.08M	0.21%	34

Samsara BioCapital's SNCE Position: Q1 2024 in Review

Samsara BioCapital sold out of Science 37 Holdings, Inc. Common Stock (SNCE) in Q1 2024, closing a stake of 45,000 shares — an estimated $240K sold.

Samsara BioCapital first reported a position in SNCE in Q4 2020 and held it in 12 quarters. The position peaked at $11.2M in Q4 2021. 0 funds tracked by Wall St. Rank hold SNCE as of Q1 2024.

Samsara BioCapital reported no remaining Science 37 Holdings, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Samsara BioCapital sold 45,000 Science 37 Holdings, Inc. Common Stock shares in Q1 2024, an estimated $240K.
Samsara BioCapital first reported a position in Science 37 Holdings, Inc. Common Stock in Q4 2020 and held it in 12 quarters.
Samsara BioCapital's Science 37 Holdings, Inc. Common Stock position peaked at $11.2M in Q4 2021.
0 funds tracked by Wall St. Rank held Science 37 Holdings, Inc. Common Stock as of Q1 2024.

Based on Samsara BioCapital's 13F filing for Q1 2024, filed 15 May 2024.